News About: Pharm. Industry
KRPIA appoints new chairman
The Korea Research-based Pharmaceutical Industry Association appointed on March 26 M. Richter, president of Boehringer Ingelheim Korea, the 6th chairman who will succeed an incumbent chairman Jan Peterse of Pharmacia ...
KPMA to enforce fair competition code for pharmaceutical firms
The Korea Pharmaceutical Manufacturers Association held an explanatory session towards the revised fair trade code on March 25, noting that if those firms, which were subject to the first collective order on the groun...
Local companies blocking Norvasc monopolistic sales.
Pfizer Korea has monopolized Norvasc (amlodipine besylate), an antihypertensive drug on the market with annual sales of about 120 billion won last year, which seems to be curbed by local competitors, Hanmi, CJ and CKD...
MSD Korea to collaborate with Zuellig Pharma Korea
MSD Korea said it would enter into a drug distribution contract with Zuellig Pharma Korea from this April 1 in a bid to operate more efficient distribution system and cope with sufficient human resources and broad ran...
Pfizer Korea decides to lower insurance price of Norvasc by 1 won
Pfizer Korea said the government should cut down the reimbursement price of Norvasc (amlopidpine), a long-acting calcium channel blocker, by 1 won from this April.
The company said, "The government has informed us...
Chosun Pharm concentrates its efforts on streamlining its organizations as herbal maker
Chosun Pharm cerebrated its 78-year foundation day on March 14, renewing its determination as re-born herbal maker.
In his congratulatory speech, Park Chong-whan, a committee chief for management normalization sai...
KPMA member companies to keep compliance with fair trade provisions.
The Korea pharmaceutical manufacturers association (KPMA) asked all member companies strictly to comply with the fair trade regulations in order to keep their management transparency and fair trade climates in the mar...
Inevitable price reduction of simvastatin preparations probable
Influenced by the voluntary reimbursement price cut of MSD Korea's Zocor, which has dominated the domestic anti-hyperlipemic market, the overall price of its generic versions seems likely to be lowered in rows.
MSD...
Pharmaceutical technologies fast transferring to China
The Korea New Drug R&D Association (KNDRDA) and the Chinese National Health Science and Technology Industrial Base (CNHSTIB) have made a visible treaty framework for the pharmaceutical technology transfer under the ti...
Drug industry: Information control system requires urgent improvement.
The information control system in the domestic drug industry stood at a pretty much infant level, requiring an urgent improvement by extending the knowledge management system (KMS) to the industry as early as possible...